scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
3.460
+0.100 (2.98%)
Nov 21, 2024, 4:00 PM EST - Market closed
scPharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 173 | 225 | 244 | 137 | 145 | 105 | |
Market Cap Growth | -10.64% | -7.91% | 77.80% | -4.98% | 37.04% | 51.05% | |
Enterprise Value | 128 | 173 | 210 | 73 | 50 | 43 | |
Last Close Price | 3.36 | 6.27 | 7.17 | 5.02 | 5.29 | 5.66 | |
PS Ratio | 4.53 | 16.54 | - | - | - | - | |
PB Ratio | 5.48 | 6.04 | 3.37 | 2.43 | 1.76 | 2.05 | |
P/TBV Ratio | 7.43 | 6.04 | 3.37 | 2.43 | 1.76 | 2.05 | |
EV/Sales Ratio | 4.23 | 12.74 | - | - | - | - | |
Debt / Equity Ratio | 1.71 | 1.08 | 0.52 | 0.31 | 0.25 | 0.41 | |
Asset Turnover | 0.26 | 0.12 | - | - | - | - | |
Inventory Turnover | 0.73 | 0.76 | - | - | - | - | |
Quick Ratio | 6.67 | 6.20 | 16.13 | 5.07 | 11.28 | 13.93 | |
Current Ratio | 8.08 | 7.08 | 16.63 | 5.27 | 11.57 | 14.44 | |
Return on Equity (ROE) | -200.65% | -99.97% | -57.16% | -40.44% | -48.24% | -50.72% | |
Return on Assets (ROA) | -34.44% | -31.67% | -22.24% | -17.16% | -20.08% | -24.05% | |
Return on Capital (ROIC) | -46.24% | -36.97% | -24.58% | -18.29% | -21.41% | -25.31% | |
Earnings Yield | -46.68% | -24.38% | -15.09% | -20.41% | -22.29% | -31.29% | |
FCF Yield | -41.11% | -26.37% | -14.17% | -19.78% | -19.16% | -28.86% | |
Buyback Yield / Dilution | -11.46% | -35.81% | -3.68% | -11.33% | -32.09% | -0.24% | |
Total Shareholder Return | -11.46% | -35.81% | -3.68% | -11.33% | -32.09% | -0.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.